Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Sleep Medicine

Daily Living and Long-Term Success with OSA

At a Glance

Long-term OSA care works best when PAP is used during all sleep, app trends are reviewed, and weight or medication changes are discussed with a clinician. Repeat testing may be needed if symptoms return, health changes, or treatment changes.

Managing Obstructive Sleep Apnea (OSA) is a long-term commitment that extends far beyond your initial diagnosis. While starting treatment is a major milestone, the “maintenance phase” of your care involves monitoring your data, adjusting your lifestyle, and knowing when your treatment needs a professional tune-up [1][2].

Daily Lifestyle: Protecting Your Airway

Your airway’s stability is not fixed; it can be influenced by what you consume during the day, particularly in the hours before bed [3].

  • Alcohol and Sedatives: Substances like alcohol, benzodiazepines (anti-anxiety meds), and certain sleep aids act as muscle relaxants [4][5]. They can cause the muscles in your throat to relax more deeply than usual, making your airway more likely to collapse [3]. They also dampen your brain’s “arousal threshold,” meaning your body may wait longer to wake you up when your oxygen levels drop, leading to deeper and more dangerous oxygen desaturations [4][6].
  • Medication Review: If you are prescribed opioids for pain or gabapentinoids for nerve issues, discuss your OSA diagnosis with your prescribing doctor [3][7]. These medications can sometimes shift your apnea from “obstructive” to “central” or worsen your overall breathing stability [8][9]. Warning: Do not abruptly stop prescribed medications (such as opioids or benzodiazepines) without consulting your prescriber.
  • Weight Management: Weight is a powerful lever in OSA severity [10]. While weight loss can significantly reduce your apnea score, significant weight gain can make your current PAP pressure settings ineffective [11][2].

Monitoring Your Progress

Most modern PAP machines sync with smartphone apps that allow you to track your own treatment efficacy in real-time [12]. Use this data to spot long-term trends rather than reacting to minor nightly fluctuations.

  • Usage Hours: Aim to use the machine for your entire sleep period—ideally 7+ hours, including naps. (Note: Many insurance companies require at least 4 hours of use on 70% of nights for reimbursement. This is a minimum billing standard, not the clinical ideal for protecting your health) [1][13].
  • Residual AHI: This is the number of breathing events you are still having while wearing the mask [14]. Ideally, this number should be below 5, though the machine estimate can be distorted by mask leaks [15]. Do not independently change your pressure settings. If your number is consistently high, your pressure may need to be adjusted by your doctor [14][15].
  • Leak Rate: If your app shows a high leak rate, your mask may not be sealing correctly [15]. Large leaks can make the treatment ineffective and can irritate your eyes or dry out your mouth [16].

When to Request a Follow-Up Sleep Study

You do not typically need a repeat sleep study if you are feeling well and using your PAP machine consistently [2]. However, the American Academy of Sleep Medicine (AASM) recommends a follow-up study in these specific situations [2][17]:

  1. Significant Weight Change: If you experience clinically significant weight gain or loss, your airway anatomy has likely changed [2].
  2. Returning Symptoms: If snoring, daytime sleepiness, or morning headaches return despite “good” scores on your PAP app [2]. (Note: these symptoms can also have other medical causes, so have them evaluated by your doctor).
  3. New Heart Issues: If you are newly diagnosed with conditions like Atrial Fibrillation (AFib), heart failure, or high blood pressure that is difficult to control [2].
  4. Non-PAP Treatments: If you switch from CPAP to a dental appliance or have airway surgery, a follow-up study is required to ensure the new treatment is actually working [2][18].

Overlap Syndrome: OSA and COPD

Some patients have “Overlap Syndrome,” which is the combination of OSA and Chronic Obstructive Pulmonary Disease (COPD) [19]. This combination is more than the sum of its parts; it often leads to deeper oxygen drops and a higher risk of heart strain or COPD flare-ups [19][20]. If you have both, your doctor may require more intensive monitoring, such as overnight oxygen checks or specialized lab studies that measure carbon dioxide (CO2) levels to ensure you aren’t “retaining” gas overnight [21][22]. Management for overlap syndrome focuses on optimizing both your inhalers and your PAP therapy to protect your lungs and heart simultaneously [23][24].

Common questions in this guide

How long should I use my PAP machine each night?
Use PAP for the entire time you sleep, including naps, with about seven or more hours per night as a practical goal. Insurance rules may count four hours on at least 70% of nights as adequate for coverage, but that is a billing standard rather than the ideal amount for health protection.
What does residual AHI mean on a PAP app?
Residual AHI is the estimated number of breathing interruptions that occur while you are wearing the PAP mask. A value below 5 is often a useful target, but mask leaks can make the estimate less reliable. If the number stays high, ask your clinician to review it rather than changing the pressure yourself.
What should I do if my PAP mask has a high leak rate?
A high leak rate usually means the mask is not sealing well, which can reduce treatment effectiveness and cause dry mouth or eye irritation. Ask your healthcare professional or equipment provider to check the fit, adjust the mask, or help you choose a better size or style.
Can alcohol or medications make sleep apnea worse?
Alcohol, benzodiazepines, and some sleep medicines can relax throat muscles and make the airway more likely to close. Opioids and gabapentinoids can also affect breathing stability. Never stop a prescribed medicine suddenly; discuss its risks and safer options with the prescriber.
When might I need another sleep study after starting PAP?
A repeat study may be appropriate after a significant weight change, if snoring or daytime symptoms return, if a new heart condition develops, or if you change from PAP to an oral appliance or airway surgery. People who feel well and use PAP consistently do not usually need routine repeat testing.
What is OSA-COPD overlap syndrome, and how is it monitored?
OSA-COPD overlap syndrome means a person has both obstructive sleep apnea and chronic obstructive pulmonary disease. Together, these conditions can cause deeper overnight oxygen drops and increase strain on the heart or risk of COPD flare-ups. Monitoring may include overnight oxygen and carbon dioxide checks while clinicians optimize both inhaler and PAP treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current PAP app data, is my 'residual AHI' low enough, or do we need to adjust my pressure settings?
  2. 2.How does the alcohol or the specific medications I take (like muscle relaxants or sleep aids) affect my airway stability at night?
  3. 3.Since I have both OSA and a lung condition (COPD), do I need a follow-up study that includes carbon dioxide (CO2) monitoring?
  4. 4.Now that I've lost/gained significant weight, how long should I wait before we do a repeat sleep study to see if my treatment needs have changed?
  5. 5.If my PAP data shows a high 'leak rate,' what are the specific steps we should take to find a better mask seal?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline.

    Patil SP, Ayappa IA, Caples SM, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2019; (15(2)):335-343 doi:10.5664/jcsm.7640.

    PMID: 30736887
  2. 2

    Use of polysomnography and home sleep apnea tests for the longitudinal management of obstructive sleep apnea in adults: an American Academy of Sleep Medicine clinical guidance statement.

    Caples SM, Anderson WM, Calero K, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2021; (17(6)):1287-1293 doi:10.5664/jcsm.9240.

    PMID: 33704050
  3. 3

    Opioids and obstructive sleep apnea.

    Freire C, Sennes LU, Polotsky VY

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2022; (18(2)):647-652 doi:10.5664/jcsm.9730.

    PMID: 34672945
  4. 4

    Hypnotics on Obstructive Sleep Apnea Severity and Endotypes: A Systematic Review and Meta-Analysis.

    Messineo L, Sands SA, Labarca G

    American journal of respiratory and critical care medicine 2024; (210(12)):1461-1474 doi:10.1164/rccm.202403-0501OC.

    PMID: 39042859
  5. 5

    The Physiology and Maintenance of Respiration: A Narrative Review.

    Webster LR, Karan S

    Pain and therapy 2020; (9(2)):467-486 doi:10.1007/s40122-020-00203-2.

    PMID: 33021707
  6. 6

    Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients.

    Mir S, Wong J, Ryan CM, et al.

    ERJ open research 2020; (6(3)) doi:10.1183/23120541.00093-2020.

    PMID: 32864381
  7. 7

    Perioperative considerations for adult patients with obstructive sleep apnea.

    Weingarten TN, Sprung J

    Current opinion in anaesthesiology 2022; (35(3)):392-400 doi:10.1097/ACO.0000000000001125.

    PMID: 35671031
  8. 8

    Pathogenesis of sleep-disordered breathing in the setting of opioid use: a multiple mediation analysis using physiology.

    Orr JE, Malhotra A, Gruenberg E, et al.

    Sleep 2024; (47(11)) doi:10.1093/sleep/zsae090.

    PMID: 38605676
  9. 9

    Chronic opioid use and central sleep apnea: a review of the prevalence, mechanisms, and perioperative considerations.

    Correa D, Farney RJ, Chung F, et al.

    Anesthesia and analgesia 2015; (120(6)):1273-85 doi:10.1213/ANE.0000000000000672.

    PMID: 25988636
  10. 10

    Weight Management in Obstructive Sleep Apnea: Medical and Surgical Options.

    Tham KW, Lee PC, Lim CH

    Sleep medicine clinics 2019; (14(1)):143-153 doi:10.1016/j.jsmc.2018.10.002.

    PMID: 30709529
  11. 11

    Effect of an Interdisciplinary Weight Loss and Lifestyle Intervention on Obstructive Sleep Apnea Severity: The INTERAPNEA Randomized Clinical Trial.

    Carneiro-Barrera A, Amaro-Gahete FJ, Guillén-Riquelme A, et al.

    JAMA network open 2022; (5(4)):e228212 doi:10.1001/jamanetworkopen.2022.8212.

    PMID: 35452108
  12. 12

    Impact of the COVID-19 pandemic on positive airway pressure adherence and patients' perspectives in Greece: the role of telemedicine.

    Bouloukaki I, Pataka A, Mauroudi E, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2023; (19(10)):1743-1751 doi:10.5664/jcsm.10664.

    PMID: 37218340
  13. 13

    Correlation between positive airway pressure and medication adherence: the healthy user effect.

    Lettieri MJ, Warren WA, Walter RJ, Lettieri CJ

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2024; (20(7)):1087-1092 doi:10.5664/jcsm.11092.

    PMID: 38421002
  14. 14

    Detection of upper airway status and respiratory events by a current generation positive airway pressure device.

    Li QY, Berry RB, Goetting MG, et al.

    Sleep 2015; (38(4)):597-605 doi:10.5665/sleep.4578.

    PMID: 25409101
  15. 15

    The Importance of Mask Selection on Continuous Positive Airway Pressure Outcomes for Obstructive Sleep Apnea. An Official American Thoracic Society Workshop Report.

    Genta PR, Kaminska M, Edwards BA, et al.

    Annals of the American Thoracic Society 2020; (17(10)):1177-1185 doi:10.1513/AnnalsATS.202007-864ST.

    PMID: 33000960
  16. 16

    Feasibility and acceptability of switching from a previous-generation to a new-generation mask for positive airway pressure therapy of sleep apnea using remote care.

    Zhu X, Benjafield A, Deas R, et al.

    Sleep medicine: X 2024; (8()):100128 doi:10.1016/j.sleepx.2024.100128.

    PMID: 39498349
  17. 17

    [Sleepiness, continuous positive airway pressure and the obstructive sleep apnea hypopnea syndrome].

    Lerousseau L

    Revue des maladies respiratoires 2018; (35(2)):116-133 doi:10.1016/j.rmr.2017.04.005.

    PMID: 29454715
  18. 18

    [OSA in adults: Role of the mandibular advancement device (MAD)].

    Dupuy-Bonafe I, Francois C, Lachiche V, et al.

    L' Orthodontie francaise 2019; (90(3-4)):389-399 doi:10.1051/orthodfr/2019024.

    PMID: 34643524
  19. 19

    Current evidence on prevalence and clinical outcomes of co-morbid obstructive sleep apnea and chronic obstructive pulmonary disease: A systematic review.

    Shawon MS, Perret JL, Senaratna CV, et al.

    Sleep medicine reviews 2017; (32()):58-68 doi:10.1016/j.smrv.2016.02.007.

    PMID: 28169105
  20. 20

    Mortality prediction in chronic obstructive pulmonary disease and obstructive sleep apnea.

    Bae E, Kwak N, Choi SM, et al.

    Sleep medicine 2021; (87()):143-150 doi:10.1016/j.sleep.2021.09.011.

    PMID: 34607112
  21. 21

    Reliability of Home Nocturnal Oximetry in the Diagnosis of Overlap Syndrome in COPD.

    Lajoie AC, Sériès F, Bernard S, et al.

    Respiration; international review of thoracic diseases 2020; (99(2)):132-139 doi:10.1159/000505299.

    PMID: 31995805
  22. 22

    Predicting CPAP failure in patients with suspected sleep hypoventilation identified on ambulatory testing.

    Braganza MV, Hanly PJ, Fraser KL, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2020; (16(9)):1555-1565 doi:10.5664/jcsm.8616.

    PMID: 32501210
  23. 23

    Chronic obstructive pulmonary disease and obstructive sleep apnea overlap: who to treat and how?

    Sunwoo BY, Raphelson JR, Malhotra A

    Expert review of respiratory medicine 2024; (18(7)):527-537 doi:10.1080/17476348.2024.2384036.

    PMID: 39036943
  24. 24

    Management of Patients with Asthma, COPD, and OSA in Outpatient Unit: ACOSOU-Global Perspectives and Challenges.

    Duong-Quy S, Huynh-Anh T, Vo-Pham-Minh T, et al.

    Pulmonary therapy 2026; (12(1)):117-144 doi:10.1007/s41030-026-00345-2.

    PMID: 41557220

This page is for informational purposes only and does not constitute medical advice. Do not change PAP settings or stop prescribed medicines without discussing it with your healthcare professional.

Get notified when new evidence is published on obstructive sleep apnea syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.